Sana Biotechnology Inc [SANA] stock prices are up 2.17% to $4.23 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The SANA shares have gain 6.02% over the last week, with a monthly amount drifted -1.63%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Sana Biotechnology Inc [NASDAQ: SANA] stock has seen the most recent analyst activity on June 26, 2024, when Rodman & Renshaw initiated its Buy rating and assigned the stock a price target of $16. Previously, H.C. Wainwright upgraded its rating to Buy on January 16, 2024, and kept the price target unchanged to $12. On September 25, 2023, JMP Securities initiated with a Mkt Outperform rating and assigned a price target of $9 on the stock. Citigroup started tracking the stock assigning a Buy rating and suggested a price target of $8 on September 05, 2023. TD Cowen initiated its recommendation with a Market Perform. In a note dated March 01, 2021, Morgan Stanley initiated an Overweight rating and provided a target price of $40 on this stock.
The stock price of Sana Biotechnology Inc [SANA] has been fluctuating between $2.74 and $12.00 over the past year. Currently, Wall Street analysts expect the stock to reach $12 within the next 12 months. Sana Biotechnology Inc [NASDAQ: SANA] shares were valued at $4.23 at the most recent close of the market. An investor can expect a potential return of 183.69% based on the average SANA price forecast.
Analyzing the SANA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.4, Equity is -0.72 and Total Capital is -0.42. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.29.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.08 points at the first support level, and at 3.93 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.37, and for the 2nd resistance point, it is at 4.50.
Ratios To Look Out For
It’s worth pointing out that Sana Biotechnology Inc [NASDAQ:SANA]’s Current Ratio is 5.20. On the other hand, the Quick Ratio is 5.20, and the Cash Ratio is 2.74.
Transactions by insiders
Recent insider trading involved Mulligan Richard, Director, that happened on Sep 24 ’24 when 0.15 million shares were sold. Director, Mulligan Richard completed a deal on Sep 25 ’24 to sell 0.15 million shares. Meanwhile, Director RICHARD MULLIGAN bought 0.15 million shares on Sep 25 ’24.
